Substituted indazole derivatives
US5958953A · kind A · utility
16Cited by
1References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 25, 1997 |
| Grant date | Sep 28, 1999 |
| Priority date | — |
| Expiry date | Jun 25, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of the formula ##STR1## and to pharmaceutically acceptable salts thereof, wherein the broken line in formula I indicates a single or double bond, and wherein R, R.sub.1, X.sub.1 and X.sub.2 are as defined herein. The invention further relates to pharmaceutical compositions containing the compounds of formula I, and to methods of inhibiting phosphodiesterase type IV or the production of tumor necrosis factor in a mammal by administering the compounds of formula I to said mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.